ArticleTargeted oncology2019

Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study.

Jwa Hoon Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.